In the intricate world of pharmaceutical research and development, having access to high-quality chemical intermediates is non-negotiable. Lapatinib, identified by its CAS number 231277-92-2, stands out as a significant pharmaceutical intermediate with critical applications in oncology research. For procurement managers and R&D scientists, understanding the properties and sourcing channels for such compounds is paramount.

Lapatinib is primarily recognized as an antineoplastic agent and a potent tyrosine kinase inhibitor. Its molecular structure and purity directly influence its efficacy in preclinical studies and potential therapeutic applications. When you search for 'Lapatinib CAS 231277-92-2 manufacturer', you are likely looking for a supplier that can provide this compound with a high degree of purity, typically exceeding 98%. This ensures that experimental results are accurate and reproducible, which is essential for advancing cancer research.

Sourcing from China has become a common and often cost-effective strategy for acquiring such specialized chemicals. Manufacturers in China offer competitive pricing for Lapatinib, making it accessible for a wider range of research projects. However, it is vital to partner with reputable suppliers who can guarantee not only the best Lapatinib price but also consistent quality and reliable delivery. Look for suppliers who provide detailed product specifications, including appearance (white to light yellow solid), molecular formula (C29H26ClFN4O4S), and molecular weight (581.0575432).

Beyond its chemical identity, understanding Lapatinib's role is key. As a pharmaceutical intermediate, it serves as a building block for more complex molecules or as a research tool itself to study cellular pathways. Its application in cancer research, especially its ability to inhibit specific tyrosine kinases, makes it a sought-after compound for drug discovery and development programs.

In conclusion, when your research demands Lapatinib (CAS 231277-92-2), prioritize purity and supplier reliability. Exploring options from established China manufacturers ensures you receive a quality pharmaceutical intermediate at a competitive price, facilitating your critical work in antineoplastic and cancer therapy research.